# SMAD2

## Overview
SMAD2 is a gene that encodes the SMAD family member 2 protein, a critical intracellular mediator in the Transforming Growth Factor-β (TGF-β) signaling pathway. This protein is categorized as a transcriptional modulator and plays a pivotal role in regulating gene expression in response to TGF-β signals. SMAD2 is characterized by its two main domains: the MH1 domain, which is involved in DNA binding, and the MH2 domain, which facilitates protein-protein interactions. Unlike other receptor-regulated SMADs, SMAD2 contains a unique insert in its MH1 domain that prevents direct DNA binding, necessitating its interaction with other transcription factors to exert its regulatory functions (Schmierer2007TGFβ–SMAD; Massagué2005Smad). The protein undergoes phosphorylation upon activation, forming complexes with SMAD4 to translocate into the nucleus and modulate transcription. SMAD2 is essential for various cellular processes, including embryonic development, tissue homeostasis, and cellular differentiation, and its dysregulation is implicated in several pathological conditions, such as Loeys-Dietz syndrome and tissue fibrosis (Hu2018New; Massagué2005Smad).

## Structure
SMAD2 is a protein that plays a critical role in the TGF-β signaling pathway. It contains two main domains: the MH1 (Mad Homology 1) domain, which is involved in DNA binding, and the MH2 (Mad Homology 2) domain, which facilitates protein-protein interactions. The MH1 domain of SMAD2 includes a unique 30-amino acid E3 insert, which is highly conserved and influences its DNA-binding capability by adopting various conformations (Aragón2019Structural). The MH2 domain is crucial for interactions with other proteins, such as the TGF-β receptor complex, and contains a basic pocket that may serve as a docking site for phosphorylated receptors (Attisano2001Thesmads).

The SMAD2 protein can exist in multiple conformations, including monomers, dimers, and trimers, even without activation, with dimers acting as key intermediates in forming functional quaternary structures (Gomes2021Conformational). SMAD2 undergoes phosphorylation, a post-translational modification essential for its activation and function. The protein can form complexes with other SMAD proteins, contributing to its quaternary structure (Miyazono2020Structural). Splice variants of SMAD2 result in different isoforms, such as SMAD2β, which have distinct functional properties (Aragón2019Structural).

## Function
SMAD2 is a critical component of the TGF-β signaling pathway, functioning as a transcriptional modulator in healthy human cells. Upon activation by TGF-β receptors, SMAD2 is phosphorylated and forms a complex with SMAD4, which translocates to the nucleus to regulate gene expression (Schmierer2007TGFβ–SMAD; Massagué2005Smad). SMAD2 is unique among receptor-regulated SMADs due to an insert in its MH1 domain that prevents direct DNA binding, necessitating its interaction with other transcription factors for DNA binding and transcriptional regulation (Schmierer2007TGFβ–SMAD; Massagué2005Smad).

In the nucleus, SMAD2-containing complexes are involved in chromatin remodeling and recruit various co-regulators to modulate transcription (Schmierer2007TGFβ–SMAD; Brown2007A). SMAD2 plays a vital role in embryonic development, as evidenced by the embryonic lethal phenotype observed in Smad2-null mice (Massagué2005Smad). It is also involved in regulating cellular processes such as growth and differentiation, influencing organismal outcomes like tissue homeostasis (Brown2007A; Johnsen2002Transcriptional). The dynamic nucleocytoplasmic shuttling of SMAD2 ensures its responsiveness to TGF-β signaling, maintaining a balance between its active and inactive states (Schmierer2007TGFβ–SMAD; Massagué2005Smad).

## Clinical Significance
Mutations and alterations in the SMAD2 gene are associated with several diseases and conditions. SMAD2 is implicated in Loeys-Dietz syndrome (LDS), a connective tissue disorder characterized by vascular abnormalities and skeletal manifestations. Mutations in SMAD2, particularly in the MH2 domain, contribute to LDS type 5 (LDS5) by affecting the oligomerization with SMAD4 and activation of downstream transcription, leading to dysregulation of the TGF-β signaling pathway (Schepers2018A).

In metabolic syndrome (MetS), the SMAD2 rs11082639 single nucleotide polymorphism (SNP) is significantly associated with increased risk, influencing traits such as waist circumference and fasting glucose levels. This SNP, along with interactions with TGFBR2, suggests a role for SMAD2 in lipid metabolism and insulin resistance, contributing to MetS development (Lin2017Transforming).

SMAD2 is also involved in tissue fibrosis, including renal and liver fibrosis. Alterations in SMAD2 expression can exacerbate fibrotic conditions by mediating TGF-β/Smad signaling, which is crucial in the pathogenesis of chronic kidney disease and liver diseases (Hu2018New). These findings highlight the clinical significance of SMAD2 in various pathological conditions.

## Interactions
SMAD2 is a key mediator in the Transforming Growth Factor-β (TGF-β) signaling pathway, where it interacts with various proteins to regulate cellular processes. SMAD2 forms complexes with SMAD4, which translocate to the nucleus to regulate gene transcription (Brown2008Identification). It also interacts with Sirt1, a NAD+ dependent type III histone deacetylase, which modulates TGF-β regulated transcription. This interaction is enhanced by TGF-β stimulation and is dependent on the acetylation status of SMAD2 (GarcíaVizcaíno2017Sirt1).

SMAD2 interacts with MAN1, an integral protein of the inner nuclear membrane, which binds to SMAD2 and SMAD3, antagonizing TGF-β signaling. This interaction is mediated by the MH2 domains of SMAD2 and SMAD3 (Lin2004MAN1). SMAD2 also associates with Zizimin1, a guanine nucleotide exchange factor, which may play a role in actin cytoskeleton regulation and TGF-β1-mediated transcriptional responses (Brown2008Identification).

Additionally, SMAD2 interacts with Smurf2, a ubiquitin E3 ligase, which mediates its proteasome-dependent degradation, highlighting its role in TGF-β signaling (Lin2000Smurf2). These interactions underscore the complexity of SMAD2's role in cellular signaling pathways.


## References


[1. (Lin2017Transforming) Eugene Lin, Po-Hsiu Kuo, Yu-Li Liu, Albert C. Yang, and Shih-Jen Tsai. Transforming growth factor-β signaling pathway-associated genes smad2 and tgfbr2 are implicated in metabolic syndrome in a taiwanese population. Scientific Reports, October 2017. URL: http://dx.doi.org/10.1038/s41598-017-14025-4, doi:10.1038/s41598-017-14025-4. This article has 51 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-017-14025-4)

[2. (Brown2007A) Kimberly A. Brown, Jennifer A. Pietenpol, and Harold L. Moses. A tale of two proteins: differential roles and regulation of smad2 and smad3 in tgf‐β signaling. Journal of Cellular Biochemistry, 101(1):9–33, March 2007. URL: http://dx.doi.org/10.1002/jcb.21255, doi:10.1002/jcb.21255. This article has 292 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcb.21255)

[3. (Lin2000Smurf2) Xia Lin, Min Liang, and Xin-Hua Feng. Smurf2 is a ubiquitin e3 ligase mediating proteasome-dependent degradation of smad2 in transforming growth factor-β signaling. Journal of Biological Chemistry, 275(47):36818–36822, November 2000. URL: http://dx.doi.org/10.1074/jbc.c000580200, doi:10.1074/jbc.c000580200. This article has 399 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.c000580200)

4. (Gomes2021Conformational) Conformational landscape of full-length Smad proteins. This article has 1 citations.

[5. (Schepers2018A) Dorien Schepers, Giada Tortora, Hiroko Morisaki, Gretchen MacCarrick, Mark Lindsay, David Liang, Sarju G. Mehta, Jennifer Hague, Judith Verhagen, Ingrid van de Laar, Marja Wessels, Yvonne Detisch, Mieke van Haelst, Annette Baas, Klaske Lichtenbelt, Kees Braun, Denise van der Linde, Jolien Roos-Hesselink, George McGillivray, Josephina Meester, Isabelle Maystadt, Paul Coucke, Elie El-Khoury, Sandhya Parkash, Birgitte Diness, Lotte Risom, Ingrid Scurr, Yvonne Hilhorst-Hofstee, Takayuki Morisaki, Julie Richer, Julie Désir, Marlies Kempers, Andrea L. Rideout, Gabrielle Horne, Chris Bennett, Elisa Rahikkala, Geert Vandeweyer, Maaike Alaerts, Aline Verstraeten, Hal Dietz, Lut Van Laer, and Bart Loeys. A mutation update on the lds-associated genestgfb2/3andsmad2/3. Human Mutation, 39(5):621–634, March 2018. URL: http://dx.doi.org/10.1002/humu.23407, doi:10.1002/humu.23407. This article has 126 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.23407)

[6. (GarcíaVizcaíno2017Sirt1) Eva María García-Vizcaíno, Sergio Liarte, José Luis Alonso-Romero, and Francisco José Nicolás. Sirt1 interaction with active smad2 modulates transforming growth factor-β regulated transcription. Cell Communication and Signaling, November 2017. URL: http://dx.doi.org/10.1186/s12964-017-0205-y, doi:10.1186/s12964-017-0205-y. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12964-017-0205-y)

[7. (Hu2018New) He-He Hu, Dan-Qian Chen, Yan-Ni Wang, Ya-Long Feng, Gang Cao, Nosratola D. Vaziri, and Ying-Yong Zhao. New insights into tgf-β/smad signaling in tissue fibrosis. Chemico-Biological Interactions, 292:76–83, August 2018. URL: http://dx.doi.org/10.1016/j.cbi.2018.07.008, doi:10.1016/j.cbi.2018.07.008. This article has 716 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cbi.2018.07.008)

[8. (Massagué2005Smad) Joan Massagué, Joan Seoane, and David Wotton. Smad transcription factors. Genes &amp; Development, 19(23):2783–2810, December 2005. URL: http://dx.doi.org/10.1101/gad.1350705, doi:10.1101/gad.1350705. This article has 3139 citations.](https://doi.org/10.1101/gad.1350705)

[9. (Johnsen2002Transcriptional) Steven A. Johnsen, Malayannan Subramaniam, Takenobu Katagiri, Ralf Janknecht, and Thomas C. Spelsberg. Transcriptional regulation of smad2 is required for enhancement of tgfβ/smad signaling by tgfβ inducible early gene. Journal of Cellular Biochemistry, 87(2):233–241, January 2002. URL: http://dx.doi.org/10.1002/jcb.10299, doi:10.1002/jcb.10299. This article has 67 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcb.10299)

[10. (Brown2008Identification) Kimberly A. Brown, Amy‐Joan L. Ham, Cara N. Clark, Nahum Meller, Brian K. Law, Anna Chytil, Nikki Cheng, Jennifer A. Pietenpol, and Harold L. Moses. Identification of novel smad2 and smad3 associated proteins in response to tgf‐β1. Journal of Cellular Biochemistry, 105(2):596–611, August 2008. URL: http://dx.doi.org/10.1002/jcb.21860, doi:10.1002/jcb.21860. This article has 42 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcb.21860)

[11. (Lin2004MAN1) Feng Lin, Juliet M. Morrison, Wei Wu, and Howard J. Worman. Man1, an integral protein of the inner nuclear membrane, binds smad2 and smad3 and antagonizes transforming growth factor-β signaling. Human Molecular Genetics, 14(3):437–445, December 2004. URL: http://dx.doi.org/10.1093/hmg/ddi040, doi:10.1093/hmg/ddi040. This article has 170 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddi040)

[12. (Miyazono2020Structural) Ken-ichi Miyazono, Tomoko Ito, Yui Fukatsu, Hikaru Wada, Akira Kurisaki, and Masaru Tanokura. Structural basis for transcriptional coactivator recognition by smad2 in tgf-β signaling. Science Signaling, December 2020. URL: http://dx.doi.org/10.1126/scisignal.abb9043, doi:10.1126/scisignal.abb9043. This article has 7 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1126/scisignal.abb9043)

[13. (Attisano2001Thesmads) Liliana Attisano and Si Tuen Lee-Hoeflich. The smads. Genome Biology, 2(8):reviews3010.1, 2001. URL: http://dx.doi.org/10.1186/gb-2001-2-8-reviews3010, doi:10.1186/gb-2001-2-8-reviews3010. This article has 295 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/gb-2001-2-8-reviews3010)

[14. (Schmierer2007TGFβ–SMAD) Bernhard Schmierer and Caroline S. Hill. Tgfβ–smad signal transduction: molecular specificity and functional flexibility. Nature Reviews Molecular Cell Biology, 8(12):970–982, December 2007. URL: http://dx.doi.org/10.1038/nrm2297, doi:10.1038/nrm2297. This article has 1035 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/nrm2297)

[15. (Aragón2019Structural) Eric Aragón, Qiong Wang, Yilong Zou, Sophie M. Morgani, Lidia Ruiz, Zuzanna Kaczmarska, Jie Su, Carles Torner, Lin Tian, Jing Hu, Weiping Shu, Saloni Agrawal, Tiago Gomes, José A. Márquez, Anna-Katerina Hadjantonakis, Maria J. Macias, and Joan Massagué. Structural basis for distinct roles of smad2 and smad3 in foxh1 pioneer-directed tgf-β signaling. Genes &amp; Development, 33(21–22):1506–1524, October 2019. URL: http://dx.doi.org/10.1101/gad.330837.119, doi:10.1101/gad.330837.119. This article has 69 citations.](https://doi.org/10.1101/gad.330837.119)